Bottlenecks in Drug Research Resolved by New AI Based Technology

Discovery of new drugs could be hastened and the need for costly and time-consuming laboratory tests could be reduced by a new AI based pattern to knowledge(P2K) technology.

A new AI based technology can significantly speed up the discovery of new drugs and reduce the need for costly and time-consuming laboratory tests, reveals a new study.

P2K can predict the binding of biosequences in seconds and potentially reduce bottlenecks in drug research. It uses artificial intelligence (AI) to leverage deep knowledge from data instead of relying solely on classical machine learning.

Use of Nanotechnology in Healthcare - Brain, Breast, Dental, Orthopedic, Ocular
Nanotechnology provides several potential solutions for many life-threatening diseases. Learn more about the role of nanotechnology in healthcare

‘Cancer patients could be benefited with the new P2K technology, which identifies the interaction between cancer treatment with proteins that helps prevent various future unknown side effects.’
Read More..

"P2K is a game changer given its ability to reveal subtle protein associations entangled in complex physiochemical environments and powerfully predict interactions based only on sequence data," said Andrew Wong, professor, Systems Design Engineering, and Founding Director, Centre for Pattern Analysis and Machine Intelligence (CPAMI).

"The ability to access this deep knowledge from proven scientific results will shift biological research going forward. P2K has the power to transform how data could be used in the future."

Although a large amount of biological sequence data has been collected, extracting meaningful and useful knowledge hasn't been easy. P2K algorithms tackle this challenge by disentangling multiple associations to identify and predict amino acid bindings that govern protein interactions.

Since P2K is much faster than existing biosequence analysis software with almost 30 per cent better prediction accuracy, it could significantly speed up the discovery of new drugs. By drawing information from databases in the Cloud, P2K could predict how tumor proteins and potential cancer treatments would interact.

Although still in the early prototype stage, Professor Wong and his team have made the online P2K system available publicly to researchers to start identifying new bio-sequence interactions.

"Putting this AI technology in the hands of biomedical researchers will generate immediate results, which could be used for future scientific discoveries," said Antonio Sze-To, research associate, Systems Design Engineering, and co-inventor of P2K.

Since it analyzes sequential data, the applicability of P2K isn't limited to biomedical research. P2K could benefit the financial industry by making useful associations and predictions for smart trading or the cybersecurity sector by predicting the likelihood of a potential cyber attack.

The research paper, "Pattern to Knowledge: Deep Knowledge-Directed Machine Learning for Residue-Residue Interaction Prediction" was recently published in Nature's Scientific Reports.

Source-Eurekalert